Assessment on Safety of New Oral Anticoagulants for Nonvalvular Atrial Fibrillation – A Single Medical Center Experience
碩士 === 國立成功大學 === 臨床藥學與藥物科技研究所 === 102 === Although new oral anticoagulants (NOACs), dabigatran and rivaroxaban, are recommended for prevention of thromboembolism in patients with atrial fibrillation especially those who cannot tolerate warfarin, safety information in Taiwan population is limited. M...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2014
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/d35hge |